Skip navigation.
Wed Mar 17 01:08:15 2010 [Write for us] | [Login/Register]
Home

Bristol-Myers Squibb

Up 80%, It's Time to Sell
by Brian Orelli - November 18, 2009 - 0 comments

After seeing shares of its spinoff Mead Johnson Nutrition (NYSE: MJN) nearly double since its IPO in February, Bristol-Myers Squibb (NYSE: BMY) has decided now's the time to sell the 83% of the baby formula producer that it still owns.

Read More...

A Big Upgrade for Bristol-Myers Squibb

Submitted by Dave Mock on Fri, 02/13/2009 - 14:26 ::
Home

Recent comments

User login

Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.

©2004-2009 All Rights Reserved

[Terms of Service] [Privacy Policy] [About us] [Editorial Policy]